141 related articles for article (PubMed ID: 17210460)
1. Cellular penetration and nuclear importation properties of 111In-labeled and 123I-labeled HIV-1 tat peptide immunoconjugates in BT-474 human breast cancer cells.
Cornelissen B; Hu M; McLarty K; Costantini D; Reilly RM
Nucl Med Biol; 2007 Jan; 34(1):37-46. PubMed ID: 17210460
[TBL] [Abstract][Full Text] [Related]
2. Site-specific conjugation of HIV-1 tat peptides to IgG: a potential route to construct radioimmunoconjugates for targeting intracellular and nuclear epitopes in cancer.
Hu M; Chen P; Wang J; Chan C; Scollard DA; Reilly RM
Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):301-10. PubMed ID: 16258763
[TBL] [Abstract][Full Text] [Related]
3. Properties of [(111)In]-labeled HIV-1 tat peptide radioimmunoconjugates in tumor-bearing mice following intravenous or intratumoral injection.
Cornelissen B; McLarty K; Kersemans V; Scollard DA; Reilly RM
Nucl Med Biol; 2008 Jan; 35(1):101-10. PubMed ID: 18158949
[TBL] [Abstract][Full Text] [Related]
4. 111In-labeled immunoconjugates (ICs) bispecific for the epidermal growth factor receptor (EGFR) and cyclin-dependent kinase inhibitor, p27Kip1.
Cornelissen B; Kersemans V; McLarty K; Tran L; Reilly RM
Cancer Biother Radiopharm; 2009 Apr; 24(2):163-73. PubMed ID: 19409037
[TBL] [Abstract][Full Text] [Related]
5. 123I-labeled HIV-1 tat peptide radioimmunoconjugates are imported into the nucleus of human breast cancer cells and functionally interact in vitro and in vivo with the cyclin-dependent kinase inhibitor, p21(WAF-1/Cip-1).
Hu M; Chen P; Wang J; Scollard DA; Vallis KA; Reilly RM
Eur J Nucl Med Mol Imaging; 2007 Mar; 34(3):368-77. PubMed ID: 17021818
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
Hu M; Wang J; Chen P; Reilly RM
Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
[TBL] [Abstract][Full Text] [Related]
7. Effect of the EGFR density of breast cancer cells on nuclear importation, in vitro cytotoxicity, and tumor and normal-tissue uptake of [111In]DTPA-hEGF.
Hu M; Scollard D; Chan C; Chen P; Vallis K; Reilly RM
Nucl Med Biol; 2007 Nov; 34(8):887-96. PubMed ID: 17998090
[TBL] [Abstract][Full Text] [Related]
8. Drug-resistant AML cells and primary AML specimens are killed by 111In-anti-CD33 monoclonal antibodies modified with nuclear localizing peptide sequences.
Kersemans V; Cornelissen B; Minden MD; Brandwein J; Reilly RM
J Nucl Med; 2008 Sep; 49(9):1546-54. PubMed ID: 18703602
[TBL] [Abstract][Full Text] [Related]
9. Radioiodinated versus radiometal-labeled anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments: optimal pharmacokinetics for therapy.
Kenanova V; Olafsen T; Williams LE; Ruel NH; Longmate J; Yazaki PJ; Shively JE; Colcher D; Raubitschek AA; Wu AM
Cancer Res; 2007 Jan; 67(2):718-26. PubMed ID: 17234783
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of 111In-labeled NOTA‑conjugated affibody molecules for visualization of HER3 expression in malignant tumors.
Andersson KG; Rosestedt M; Varasteh Z; Malm M; Sandström M; Tolmachev V; Löfblom J; Ståhl S; Orlova A
Oncol Rep; 2015 Aug; 34(2):1042-8. PubMed ID: 26059265
[TBL] [Abstract][Full Text] [Related]
11. A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice.
Panosa C; Fonge H; Ferrer-Batallé M; Menéndez JA; Massaguer A; De Llorens R; Reilly RM
Nucl Med Biol; 2015 Dec; 42(12):931-8. PubMed ID: 26385534
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional block copolymer micelles for the delivery of 111In to EGFR-positive breast cancer cells for targeted Auger electron radiotherapy.
Fonge H; Lee H; Reilly RM; Allen C
Mol Pharm; 2010 Feb; 7(1):177-86. PubMed ID: 19924993
[TBL] [Abstract][Full Text] [Related]
13. A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.
Reilly RM; Kiarash R; Sandhu J; Lee YW; Cameron RG; Hendler A; Vallis K; Gariépy J
J Nucl Med; 2000 May; 41(5):903-11. PubMed ID: 10809207
[TBL] [Abstract][Full Text] [Related]
14. Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates.
Cornelissen B; Kersemans V; Darbar S; Thompson J; Shah K; Sleeth K; Hill MA; Vallis KA
Cancer Res; 2011 Jul; 71(13):4539-49. PubMed ID: 21586614
[TBL] [Abstract][Full Text] [Related]
15. Block copolymer micelles target Auger electron radiotherapy to the nucleus of HER2-positive breast cancer cells.
Hoang B; Reilly RM; Allen C
Biomacromolecules; 2012 Feb; 13(2):455-65. PubMed ID: 22191486
[TBL] [Abstract][Full Text] [Related]
16. In vitro detection of mdr1 mRNA in murine leukemia cells with 111In-labeled oligonucleotide.
Bai J; Yokoyama K; Kinuya S; Shiba K; Matsushita R; Nomura M; Michigishi T; Tonami N
Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1523-9. PubMed ID: 15449049
[TBL] [Abstract][Full Text] [Related]
17. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
[TBL] [Abstract][Full Text] [Related]
18. Radiolabeled divalent peptidomimetic vitronectin receptor antagonists as potential tumor radiotherapeutic and imaging agents.
Harris TD; Cheesman E; Harris AR; Sachleben R; Edwards DS; Liu S; Bartis J; Ellars C; Onthank D; Yalamanchili P; Heminway S; Silva P; Robinson S; Lazewatsky J; Rajopadhye M; Barrett J
Bioconjug Chem; 2007; 18(4):1266-79. PubMed ID: 17579472
[TBL] [Abstract][Full Text] [Related]
19. In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice.
Clarke K; Lee FT; Brechbiel MW; Smyth FE; Old LJ; Scott AM
Cancer Res; 2000 Sep; 60(17):4804-11. PubMed ID: 10987290
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]